Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168659 · ClinicalTrials.gov registry record · NA
CardioFocus HeartLight Post-Approval Study
A NA study of Atrial Fibrillation, sponsored by CardioFocus.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 4
- Study locations
NCT03168659 is a NA study of Atrial Fibrillation that is actively recruiting participants, run by CardioFocus. The registered enrollment target is 250 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03168659, a NA study of Atrial Fibrillation, is actively recruiting participants, sponsored by CardioFocus.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
Conditions Studied
Interventions
- PROCEDURE Ablation
- DEVICE HeartLight
Study Locations (4)
Arizona
- University of Arizona Sarver HeartCenter - Tucson
Illinois
- University of Illinois - Chicago
New York
- Mount Sinai Hospital - New York
Virginia
- University Of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03168659
The ClinicalTrials.gov registry entry for NCT03168659 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The listed sponsor is CardioFocus, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Ablation is the first listed.
NCT03168659 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT03168659 about?
NCT03168659 is a clinical study titled "CardioFocus HeartLight Post-Approval Study". This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
What is the current status of trial NCT03168659?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2017-06-16. Estimated completion is 2028-10.
What conditions does trial NCT03168659 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT03168659?
The interventions under investigation include: Ablation (PROCEDURE), HeartLight (DEVICE).
Who is sponsoring clinical trial NCT03168659?
This trial is sponsored by CardioFocus, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168659 being conducted?
This trial has 4 study locations across Arizona, Illinois, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.